Details of the Drug

General Information of Drug (ID: DMOZGBQ)

Drug Name
BI 1291583
Indication
Disease Entry ICD 11 Status REF
Non-cystic fibrosis bronchiectasis CA24 Phase 2 [1]
Drug Type
Small molecule
Cross-matching ID
TTD ID
D5H9TE

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Dipeptidyl peptidase I (CTSC) TT4H0V2 CATC_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT05238675) A Randomised, Double-blind, Placebo-controlled, Parallel Group, Dose-finding Study Evaluating Efficacy, Safety and Tolerability of BI 1291583 qd Over at Least 24 Weeks in Patients With Bronchiectasis (AirleafTM). U.S.National Institutes of Health.
2 Clinical pipeline report, company report or official report of boehringer-ingelheim